logo

John W. Davis and Prokar Dasgupta* Departments of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA and *Guy’s Hospital, Kings College London, London, UK[...]
Ever since the potential utility of meta-analyses in the assessment of clinical data was brought to the notice of the urological community by Peter Boyle [1], they have been used i[...]
Emily A. Matuszak  and Natasha Kyprianou Departments of Toxicology, Urology and Biochemistry, University of Kentucky College of Medicine, Lexington, KY, USA Radical prostatectomy i[...]
Matthew Bultitude Urology Centre, Guy’s and St Thomas’ NHS Foundation Trust, London, UK Ureteric stents are undoubtedly a significant cause of morbidity while in situ [1].Whilst th[...]
Dirk De Ridder Department of Urology, University Hospital Leuven, Belgium The article by Mohee et al. highlights a problem that is often neglected: the outomes we see in clinical t[...]
The controversies surrounding a physician’s best treatment strategy advice to an individual patient with clinically localized prostate cancer create a continuing need for advanced [...]